Document
IPR2018-00120, No. 2006-20 Exhibit - Clofarabine From Design to Approval (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2006-20 Exhibit - Clofarabine From Design to Approval (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2002-16 Exhibit - Curing Chronic Hepatitis C ¿¿¿ The Arc of a Medical Triumph (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2002-16 Exhibit - Curing Chronic Hepatitis C ¿¿¿ The Arc of a Medical Triumph (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2015-27 Exhibit - Discovery of a ¿¿ D 2¿¿¿ Deoxy 2¿¿¿ ¿¿ Cmethyluridine Nucleotide Prodrug PSI 7977 for theTreatment of Hepatitis C Virus (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2015-27 Exhibit - Discovery of a ¿¿ D 2¿¿¿ Deoxy 2¿¿¿ ¿¿ Cmethyluridine Nucleotide Prodrug PSI 7977 for theTreatment of Hepatitis C Virus (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2007-21 Exhibit - Americas Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2007-21 Exhibit - Americas Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2003-17 Exhibit - FDA Approves Game Changer Hepatitis C Drug Sofosbuvir (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2003-17 Exhibit - FDA Approves Game Changer Hepatitis C Drug Sofosbuvir (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00119, No. 2011 Exhibit - FDA Approves Pill to Treat Hepatitis C (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00119, No. 2011 Exhibit - FDA Approves Pill to Treat Hepatitis C (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00119, No. 2012 Exhibit - FDA Approves Gilead¿¿¿s Hepatitis C Drug (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00119, No. 2012 Exhibit - FDA Approves Gilead¿¿¿s Hepatitis C Drug (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00119, No. 2019 Exhibit - Prodrugs of Phosphates, Phosphonates, and Phosphinates (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00119, No. 2019 Exhibit - Prodrugs of Phosphates, Phosphonates, and Phosphinates (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00119, No. 1003-2 Exhibit - Curriculum Vitae of Joseph M Fortunak, PhD (P.T.A.B. Oct. 25, 2017)
Cite Document
IPR2018-00119, No. 1003-2 Exhibit - Curriculum Vitae of Joseph M Fortunak, PhD (P.T.A.B. Oct. 25, 2017)
+ More Snippets
Document
IPR2018-00119, No. 1012-11 Exhibit - McGuigan 2006 (P.T.A.B. Oct. 25, 2017)
Cite Document
IPR2018-00119, No. 1012-11 Exhibit - McGuigan 2006 (P.T.A.B. Oct. 25, 2017)
+ More Snippets
Document
IPR2018-00120, No. 1009-8 Exhibit - McGuigan 327 (P.T.A.B. Oct. 25, 2017)
Cite Document
IPR2018-00120, No. 1009-8 Exhibit - McGuigan 327 (P.T.A.B. Oct. 25, 2017)
+ More Snippets
Document
IPR2018-00120, No. 1014-13 Exhibit - Cahard (P.T.A.B. Oct. 25, 2017)
Cite Document
IPR2018-00120, No. 1014-13 Exhibit - Cahard (P.T.A.B. Oct. 25, 2017)
+ More Snippets
Document
IPR2018-00120, No. 1003-2 Exhibit - Curriculum Vitae of Joseph M Fortunak, PhD (P.T.A.B. Oct. 25, 2017)
Cite Document
IPR2018-00120, No. 1003-2 Exhibit - Curriculum Vitae of Joseph M Fortunak, PhD (P.T.A.B. Oct. 25, 2017)
+ More Snippets
Document
IPR2018-00119, No. 1010-9 Exhibit - Wagner (P.T.A.B. Oct. 25, 2017)
Cite Document
IPR2018-00119, No. 1010-9 Exhibit - Wagner (P.T.A.B. Oct. 25, 2017)
+ More Snippets
Document
IPR2018-00119, No. 1011-10 Exhibit - Prusoff (P.T.A.B. Oct. 25, 2017)
Cite Document
IPR2018-00119, No. 1011-10 Exhibit - Prusoff (P.T.A.B. Oct. 25, 2017)
+ More Snippets